HBHA-Induced Polycytotoxic CD4+ T Lymphocytes Are Associated with the Control of Mycobacterium tuberculosis Infection in Humans-Reference-Cited by-同舟云学术

HBHA-Induced Polycytotoxic CD4+ T Lymphocytes Are Associated with the Control of Mycobacterium tuberculosis Infection in Humans

Published:2018-12-17 Issue:2 Volume:202 Page:421-427
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Aerts Laetitia,Selis Elodie,Corbière Véronique,Smits Kaat^ORCID,Van Praet Anne,Dauby Nicolas^ORCID,Petit Emmanuelle^ORCID,Singh Mahavir,Locht Camille,Dirix Violette,Mascart Françoise

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Epidemiology: A mortal foe

2. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

3. World Health Assembly. 2013. The End TB Strategy. Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015. Geneva, Switzerland: World Health Organization. Report EB134/12. Available at: www.who.int/tb/strategy

4. Integrating knowledge ofMycobacterium tuberculosispathogenesis for the design of better vaccines

5. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals with Mycobacterium tuberculosis infection;Frontiers in Immunology;2024-08-27

2. HBHA-IGRA and cytotoxic mediators release assays for the diagnosis of cervical tuberculous lymphadenitis;Microbiology Spectrum;2023-12-12

3. Host–pathogen interactions in the context of tuberculosis infection and disease;The Challenge of Tuberculosis in the 21st Century;2023-09-01

4. Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections;Life Sciences;2023-02

5. Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field;Frontiers in Immunology;2022-12-15